AMG 277 Discriminates Against S1P3 Receptor by 50-fold. S1P1 Lead Compounds Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale. Assets Generated by EPIX Pharmaceuticals, Inc. (EPIX) and Amgen (AMGN).
11/30/2011 9:51:59 AM
More...
|
S1P1 Lead Compounds, Assets Generated by EPIX Pharmaceuticals, Inc. (EPIX) and Amgen (AMGN), Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale. Target Rationale for S1P1 Agonists Explained.
11/9/2011 6:16:48 AM
More...
|
Bristol-Myers Squibb Company (BMY) Release: Back-Up Compounds and S1P1 Lead Compounds, Assets Generated by Bristol-Myers Squibb Company (BMY). and EPIX Pharmaceuticals, Inc. (EPIX), Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale
11/3/2011 5:50:35 AM
More...
|
EPIX Pharmaceuticals, Inc. (EPIX) Release: Contractual Agreements Revealed for S1P1 Lead Compounds, AMG 369 and AMG 277, Offered for Sale at a December 8, 2011 Sealed Bid Sale
10/26/2011 6:14:36 AM
More...
|
EPIX Pharmaceuticals, Inc. (EPIX) Release: S1P1 Agonists are Currently Indicated For Treatment of Multiple Sclerosis
10/18/2011 11:58:54 AM
More...
|
EPIX Pharmaceuticals, Inc. (EPIX) Announces a Change in the May 28, 2010 Auction Sale of Imaging Agents to June 22, 2010
5/21/2010 11:05:56 AM
More...
|
EPIX Pharmaceuticals, Inc. (EPIX) Announces Additional Information Concerning the May 28, 2010 Auction Sale of EP-3600 MRI Imaging Agent
5/17/2010 10:57:50 AM
More...
|
EPIX Pharmaceuticals, Inc. (EPIX) Announces Additional Information Concerning the May 28, 2010 Auction Sale of EP-2104R MRI Imaging Agent
5/10/2010 11:06:31 AM
More...
|
EPIX Pharmaceuticals, Inc. (EPIX) Announces the May 28, 2010 Auction Sale of EP-3600 MRI Imaging Agent
5/4/2010 12:15:09 PM
More...
|
EPIX Pharmaceuticals, Inc. (EPIX) Announces the May 28, 2010 Auction Sale of EP-2104R MRI Imaging Agent
4/19/2010 10:36:39 AM
More...
|
|